Cardiovascular safety and efficacy of metformin-SGLT2i versus metformin-sulfonylureas in type 2 diabetes: systematic review and meta-analysis of randomized controlled trials
Crossref DOI link: https://doi.org/10.1038/s41598-020-80603-8
Published Online: 2021-01-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Gebrie, Desye
Getnet, Desalegn
Manyazewal, Tsegahun
Text and Data Mining valid from 2021-01-08
Version of Record valid from 2021-01-08
Article History
Received: 27 March 2020
Accepted: 16 December 2020
First Online: 8 January 2021
Competing interests
: The authors declare no competing interests.